Cerebral Vascular Dysfunction During Hypercholesterolemia
暂无分享,去创建一个
[1] F. Faraci,et al. Impaired Endothelium-Dependent Responses and Enhanced Influence of Rho-Kinase in Cerebral Arterioles in Type II Diabetes , 2005, Stroke.
[2] C. Iadecola,et al. Angiotensin II Impairs Neurovascular Coupling in Neocortex Through NADPH Oxidase–Derived Radicals , 2004, Circulation research.
[3] G. Wang,et al. Exogenous NADPH Increases Cerebral Blood Flow Through NADPH Oxidase–Dependent and –Independent Mechanisms , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[4] H. Drexler,et al. Endothelial function: a critical determinant in atherosclerosis? , 2004, Circulation.
[5] G. Diamond,et al. Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 1: diagnosis of stable ischemia and ischemic heart disease. , 2004, Circulation.
[6] C. Sobey,et al. Increased NADPH-Oxidase Activity and Nox4 Expression During Chronic Hypertension Is Associated With Enhanced Cerebral Vasodilatation to NADPH In Vivo , 2004, Stroke.
[7] C. Sobey,et al. Cerebral vascular effects of reactive oxygen species: Recent evidence for a role of NADPH‐oxidase , 2003, Clinical and experimental pharmacology & physiology.
[8] R. Clempus,et al. Vascular NAD(P)H oxidases: specific features, expression, and regulation. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[9] J. Shepherd,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial , 2003 .
[10] Barry R. Davis,et al. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). , 2002, JAMA.
[11] P. Macfarlane,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.
[12] R. Latorre,et al. Ca2+-Activated K+ Channel Inhibition by Reactive Oxygen Species , 2002 .
[13] F. Faraci,et al. Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. , 2002, American journal of physiology. Heart and circulatory physiology.
[14] Leslie A. Smith,et al. Hypercholesterolemia Impairs Endothelium-Dependent Relaxations in Common Carotid Arteries of Apolipoprotein E-Deficient Mice , 2001, Stroke.
[15] Leslie A. Smith,et al. Mechanism of Endothelial Dysfunction in Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[16] D. Granger,et al. NAD(P)H Oxidase—Derived Superoxide Mediates Hypercholesterolemia-Induced Leukocyte—Endothelial Cell Adhesion , 2001, Circulation research.
[17] D. Heistad,et al. Mechanisms That Produce Nitric Oxide–Mediated Relaxation of Cerebral Arteries During Atherosclerosis , 2001, Stroke.
[18] N. Brot,et al. Oxidative Regulation of Large Conductance Calcium-Activated Potassium Channels , 2001, The Journal of general physiology.
[19] R. Cohen,et al. Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E-deficient mice. , 2000, Journal of cardiovascular pharmacology.
[20] B. Fanburg,et al. Reactive oxygen species in cell signaling. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[21] N. Holbrook,et al. Oxidants, oxidative stress and the biology of ageing , 2000, Nature.
[22] D. Sorescu,et al. Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[23] Tsung-Yu Chen,et al. Cysteine Modification of a Putative Pore Residue in Clc-0 , 2000, The Journal of general physiology.
[24] D. Heistad,et al. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[25] C. Mallari,et al. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. , 2000, American journal of physiology. Heart and circulatory physiology.
[26] W. Lederer,et al. Calcium sparks in smooth muscle. , 2000, American journal of physiology. Cell physiology.
[27] Francisco Bezanilla,et al. Modulation of the Shaker K+Channel Gating Kinetics by the S3–S4 Linker , 2000, The Journal of general physiology.
[28] A. Demchuk,et al. Is cholesterol a risk factor for stroke?: Yes. , 1999, Archives of neurology.
[29] W. Landau,et al. Is cholesterol a risk factor for stroke?: No. , 1999, Archives of neurology.
[30] V. Hachinski. Cholesterol as a Risk Factor for Stroke , 1999 .
[31] D. Harrison,et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. , 1999, Circulation.
[32] B. Davis,et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. , 1999, Circulation.
[33] R. Collins,et al. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.
[34] M. Pfeffer,et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. , 1998, Circulation.
[35] J. Kourie,et al. Interaction of reactive oxygen species with ion transport mechanisms. , 1998, American journal of physiology. Cell physiology.
[36] T. Lüscher,et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. , 1998, Circulation.
[37] D. Harrison,et al. Vascular expression of extracellular superoxide dismutase in atherosclerosis. , 1998, The Journal of clinical investigation.
[38] D. Heistad,et al. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[39] J. Arnal,et al. 17β-Estradiol Prevents Fatty Streak Formation in Apolipoprotein E–Deficient Mice , 1997 .
[40] L. Annunziato,et al. Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[41] N. Brot,et al. Modulation of potassium channel function by methionine oxidation and reduction. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] L. Salkoff,et al. A novel calcium-sensing domain in the BK channel. , 1997, Biophysical journal.
[43] R. Sauvé,et al. Effects of Thiol-Modifying Agents on a K(Ca2+) Channel of Intermediate Conductance in Bovine Aortic Endothelial Cells , 1997, The Journal of Membrane Biology.
[44] Yong-Xiao Wang,et al. Redox Regulation of Large Conductance Ca2+-activated K+ Channels in Smooth Muscle Cells , 1997, The Journal of general physiology.
[45] P. Reinhart,et al. Redox Modulation of hslo Ca2+-Activated K+ Channels , 1997, The Journal of Neuroscience.
[46] R. Latorre,et al. Voltage-controlled gating in a large conductance Ca2+-sensitive K+channel (hslo). , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[47] C. Sobey,et al. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. , 1997, Stroke.
[48] M. Yamaguchi,et al. H2O2 modulates twitch tension and increases Po of Ca2+ release channel in frog skeletal muscle. , 1996, The American journal of physiology.
[49] M. Kakei,et al. Direct activation of the ATP-sensitive potassium channel by oxygen free radicals in guinea-pig ventricular cells: its potentiation by MgADP. , 1996, Journal of molecular and cellular cardiology.
[50] J. Neyton. A Ba2+ chelator suppresses long shut events in fully activated high-conductance Ca(2+)-dependent K+ channels. , 1996, Biophysical journal.
[51] R. Busse,et al. Endothelial dysfunction in atherosclerosis. , 1996, Journal of vascular research.
[52] R. Latorre,et al. Interaction of internal Ba2+ with a cloned Ca(2+)-dependent K+ (hslo) channel from smooth muscle , 1996, The Journal of general physiology.
[53] M. Lazdunski,et al. Susceptibility of cloned K+ channels to reactive oxygen species. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[54] M. Rubart,et al. Relaxation of Arterial Smooth Muscle by Calcium Sparks , 1995, Science.
[55] K. Pritchard,et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. , 1995, Circulation research.
[56] A. Quyyumi,et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. , 1995, The Journal of clinical investigation.
[57] C. Sen,et al. Inward potassium transport systems in skeletal muscle derived cells are highly sensitive to oxidant exposure. , 1995, Free radical biology & medicine.
[58] M. Kasha,et al. Singlet molecular oxygen in the Haber-Weiss reaction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[59] J. Turrens,et al. Hydrogen peroxide metabolism in skeletal muscle mitochondria. , 1994, Archives of biochemistry and biophysics.
[60] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[61] J. Slattery,et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.
[62] A. J. Williams,et al. Modification of the gating of the cardiac sarcoplasmic reticulum Ca(2+)-release channel by H2O2 and dithiothreitol. , 1994, The American journal of physiology.
[63] O. H. Bing. Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. , 1994, Journal of molecular and cellular cardiology.
[64] E. Stefani,et al. Calcium-activated K+ channels as modulators of human myometrial contractile activity. , 1993, The American journal of physiology.
[65] D. Harrison,et al. Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.
[66] B. Rudy,et al. Modulation of K+ channels by hydrogen peroxide. , 1992, Biochemical and biophysical research communications.
[67] P. Black,et al. L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. , 1991, The Journal of clinical investigation.
[68] O. Aruoma,et al. Copper-ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. , 1991, The Biochemical journal.
[69] B. Neumcke,et al. ATP-sensitive potassium channels in adult mouse skeletal muscle: Characterization of the ATP-binding site , 1989, The Journal of Membrane Biology.
[70] R. Latorre,et al. Mechanisms of Cs+ blockade in a Ca2+-activated K+ channel from smooth muscle. , 1987, Biophysical journal.
[71] G. Brooks,et al. Free radicals and tissue damage produced by exercise. , 1982, Biochemical and biophysical research communications.
[72] R. Latorre,et al. Reconstitution in planar lipid bilayers of a Ca2+-dependent K+ channel from transverse tubule membranes isolated from rabbit skeletal muscle. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[73] F J Sigworth,et al. Covariance of nonstationary sodium current fluctuations at the node of Ranvier. , 1981, Biophysical journal.
[74] F. Sigworth. The variance of sodium current fluctuations at the node of Ranvier , 1980, The Journal of physiology.
[75] J. Popper,et al. Factors Related to Stroke Incidence in Hawaii Japanese Men: The Honolulu Heart Study , 1980, Stroke.
[76] W. Kannel,et al. VASCULAR DISEASE OF THE BRAIN--EPIDEMIOLOGIC ASPECTS: THE FARMINGHAM STUDY. , 1965, American journal of public health and the nation's health.
[77] R. Latorre,et al. Ca(2+)-activated K+ channel inhibition by reactive oxygen species. , 2002, American journal of physiology. Cell physiology.
[78] HOMAS,et al. The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels , 2000 .
[79] R. Latorre,et al. Voltage-Gated Calcium-Modulated Potassium Channels of Large Unitary Conductance: Structure, Diversity, and Pharmacology , 2000 .
[80] J. Kastelein,et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. , 1997, The Journal of clinical investigation.
[81] B. P. Yu,et al. Cellular defenses against damage from reactive oxygen species. , 1994, Physiological reviews.
[82] P. Poole‐Wilson,et al. Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. , 1991, Cardioscience.
[83] R Latorre,et al. Varieties of calcium-activated potassium channels. , 1989, Annual review of physiology.